1175298-09-5

Basic information

• Product Name: tert-Butyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate
• Synonyms: tert-Butyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate;(3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate;tert-butyl N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]carbamate
• CAS NO: 1175298-09-5
• Molecular Formula: C₁₇H₃₀BNO₄
• Molecular Weight: 266.12114
• Mol File: 1175298-09-5.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Density: 1.03±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
• PKA: 12.51±0.40(Predicted)
• CAS DataBase Reference: tert-Butyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate(1175298-09-5)
• EPA Substance Registry System: tert-Butyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbaMate(1175298-09-5)

Safety Data

• Hazardous Substances Data: 1175298-09-5(Hazardous Substances Data)

Usage

Uses

tert-Butyl (3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate is a reactant in the preparation of furo[3,2-c]pyridine derivatives as protein kinase inhibitors.

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 885280-38-6 (3-oxo-cyclohexyl)-carbamic acid tert-butyl ester 
• 1803033-61-5 tert-butyl N-[(1S)-3-oxocyclohexyl]carbamate 

Relevant articles and documents

PYRROLO[2,3-d]PYRIMIDINE COMPOUND OR SALT THEREOF

Provided are a novel compound or a salt thereof, and a pharmaceutical composition comprising the same, which selectively and strongly inhibit JAK3, exhibit an excellent activity for suppressing the growth of human peripheral blood monocytes and an excellent oral absorbability, and exhibits an activity of inhibiting IL-2-induced IFN-γ production in vivo. A compound represented by formula (I) [wherein X represents -CH=CH-, -NH-, a sulfur atom or an oxygen atom; and n represents an integer of 0 to 2], or a salt thereof.